Continuing Medical Education · 4.5 AMA PRA Category 1 Credits™ available


Managing Menopause After Breast Cancer

A half-day, case-based CME program for women's health clinicians, presented by OncoMenopause and the OncoMenopause Consortium®, an education initiative of HERmedicine.

In San Diego — Tuesday morning, before The Menopause Society Annual Meeting begins at 1:00 PM

Tuesday, October 20, 2026

7:00 AM – 12:30 PM · Breakfast included

$275 early-bird (ends August 31, 2026) · $325 general

Omni San Diego, Hotel at the Ballpark

“Is hormone therapy safe after breast cancer?”

Your patients are asking — and hearing conflicting answers on social media. This program moves beyond the reflexive “no” to give you evidence, nuance, and practical frameworks for the survivors in your practice.

the program


What Does This CME Program Cover?

Managing Menopause After Breast Cancer is a 4.5 AMA PRA Category 1 Credits™ program from OncoMenopause and the OncoMenopause Consortium®, held October 20, 2026, in San Diego. Led by Dr. Lisa Larkin and Dr. Maryam Lustberg, it teaches women's health clinicians how to manage menopause symptoms, contraception, and HSDD (Hypoactive Sexual Desire Disorder) in breast cancer survivors through real clinical cases.

As more women survive breast cancer, clinicians across specialties are being asked to manage menopausal symptoms in patients with a history of hormone-sensitive disease — often without dedicated training to do it confidently.

Built around case panels rather than lecture-only slides, the morning gives attendees a framework they can put to use the next week in clinic.

4.5

AMA PRA Category 1 Credits

5.5

Hours programming

3

Case panel sessions

2

Program Chairs

COURSE PANEL


Who Is Teaching This Course?

Both faculty co-chair OncoMenopause and the OncoMenopause Consortium® programming and bring frontline clinical experience treating breast cancer survivors.

  • Dr. Lisa Larkin, MD, headshot — CME faculty for OncoMenopause Consortium menopause after breast cancer program

    Lisa C. Larkin, MD, FACP, MSCP, IF

    Founder and CEO Ms.Medicine
    Founder and CEO, Concierge Medicine of Cincinnati
    Founder and Executive Director, HERmedicine and OncoMenopause Consortium
    Past President, The Menopause Society

    Cincinnati, Ohio

    Dr. Lisa Larkin is a board-certified internist and nationally recognized expert in women’s health and menopause, with more than 35 years of experience in clinical care, medical education, and healthcare innovation. Based in Cincinnati, she continues to actively practice, providing comprehensive internal medicine and consultative women’s healthcare at Concierge Medicine of Cincinnati, the multispecialty practice she founded and where she currently serves as CEO.

    Dr. Larkin is also the Founder and CEO of Ms.Medicine, a national healthcare management services organization advancing women’s health through a network of expert clinicians practicing in an innovative, membership-based care model. Additionally, she is the Founder and Executive Director of HERmedicine, a nonprofit dedicated to improving women’s health through education, clinician training, and advocacy.

    A breast cancer survivor, Dr. Larkin is a widely published author, sought-after speaker, media contributor, and consultant. She is a past board member of the International Society for the Study of Women’s Sexual Health (ISSWSH) and currently serves on the Board of Trustees of The Menopause Society, where she was the 2023 Scientific Program Chair and served as President in 2024. She is also a member of the editorial board of the journal Menopause.

  • Dr. Maryam Lustberg, MD, office headshot — Yale Breast Center oncology faculty for OncoMenopause CME

    Maryam Lustberg, MD, MPH

    Professor of Internal Medicine (Medical Oncology)
    Director, Center for Breast Cancer, Smilow Cancer Hospital and Yale Cancer Center
    Chief, Breast Medical Oncology, Yale Cancer Center
    New Haven, Connecticut

    Dr. Maryam Lustberg is Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also a Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020. She is currently participating in the American Society of Clinical Oncology (ASCO) Leadership Development Program. 

    Dr. Lustberg is an NCI-funded investigator and active in both ALLIANCE and SWOG Cancer Cooperative Groups. Dr. Lustberg collaborates widely with researchers from around the world, thriving in creating innovative multidisciplinary scientific teams. Her mentorship has been recognized by numerous awards including Best Teacher Award by Hematology Oncology Fellows and the Shining Star Award for Medical Student Mentorship.

    Nationally, Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is actively engaged in national patient advocacy organizations with a focus on improving shared decision making and increasing patient engagement in clinical trials.

Meet the Faculty

  • Dr. Milana Dolezal, MD, headshot — Stanford oncology faculty for OncoMenopause CME

    Milana V. Dolezal, MD, MSci

    Clinical Associate Professor, Medicine - Oncology
    Division of Oncology
    Stanford School of Medicine

    Dr. Milana Dolezal is a board-certified hematologist-oncologist and Clinical Associate Professor in the Division of Oncology at Stanford School of Medicine, where she practices at Stanford Medicine Cancer Center in Emeryville. Her clinical and research work centers on breast cancer, with particular expertise in triple-negative breast cancer, fertility preservation in breast cancer patients, and treatment adherence. She previously served as Clinical Scientist and Associate Medical Director in the BioOncology Therapeutics unit at Genentech, bringing rare depth in both translational science and drug development to her academic oncology practice. Dr. Dolezal has co-authored peer-reviewed research published in the Journal of Clinical Oncology, Cancer, and other leading journals, and contributed the chapter "Progression from Hormone-Dependent to Hormone-Independent Breast Cancer" to the Oxford University Press textbook Hormones, Genes and Cancer. She has presented her research at the American Association for Cancer Research, the American Society of Clinical Oncology, and the European Cancer Organisation.

  • Dr. Sharon Parish, MD, headshot — Weill Cornell sexual medicine faculty for OncoMenopause CME

    Sharon J. Parish MD, IF, NCMP

    Professor of Medicine in Clinical Psychiatry and Professor of Clinical Medicine
    Weill Cornell Medical College
    Director of Medical Services
    New York Presbyterian Hospital/ Westchester Division

    Dr. Sharon Parish is a Professor of Medicine in Clinical Psychiatry and Professor of Clinical Medicine at Weill Cornell Medical College and Director of Medical Services at New York Presbyterian Hospital/Westchester Division. An internal medicine physician, she is a fellow of the International Society for the Study of Women's Sexual Health (ISSWSH) and a Menopause Society Certified Menopause Practitioner, with a sexual medicine practice at Weill Cornell Medicine in New York City. Dr. Parish specializes in sexual medicine practice, training, and research, designing educational programs on female sexual health for medical trainees across disciplines. She has authored numerous publications on sexual dysfunction, clinical assessment, therapeutic interventions, menopause management, hormonal therapy, and genitourinary syndrome of menopause. She is Past President of ISSWSH (2014-2018), former Chair of its Clinical Practice Guidelines and Education Committees, and a longtime Board member. She served on the International Society for Sexual Medicine Board (2018-2022) and is Associate Editor for Sexual Medicine Reviews, having previously edited for the Journal of Sexual Medicine.

  • Dr. Sabrina Sahni, MD, headshot — Mayo Clinic breast medicine faculty for OncoMenopause CME

    Sabrina K. Sahni, MD, MSCP

    Breast Medicine Physician and Women’s Health Specialist
    Mayo Clinic
    Jacksonville, Florida 

    Dr. Sabrina Sahni is a board-certified family medicine physician with dual fellowships in Specialized Women’s Health and Medical Breast Medicine from Cleveland Clinic. She is a Breast Medicine Physician and Women’s Health Specialist at Mayo Clinic in Jacksonville, Florida, where she focuses on breast cancer risk assessment, new diagnoses, genetics, survivorship, and evidence-based menopause and perimenopause care across the midlife transition.

    A Menopause Society Certified Practitioner (MSCP), Dr. Sahni is known for translating complex medical science into practical, compassionate guidance patients can actually use. She is an active member of The Menopause Society, the National Consortium of Breast Centers, and the International Society for the Study of Women’s Sexual Health. Her work has been published in peer-reviewed medical journals, and she has also served as a guest editor for leading women’s health journals. She has been featured in women’s health media and podcasts and is a sought-after speaker at state and national levels.

  • Dr. Abigail Liberty, MD, headshot — Oregon Health & Science University faculty for OncoMenopause CME

    Abigail Liberty, MD, MSPH

    Assistant Professor of Obstetrics and Gynecology, School of Medicine
    Oregon Health and Science University

    Dr. Abigail Liberty is an Assistant Professor in Complex Family Planning and Women's Health Research in Reproduction Fellow in the Department of Obstetrics and Gynecology at Oregon Health & Science University, where she practices at the OHSU Center for Women's Health. She earned her MD and MSPH from the University of North Carolina at Chapel Hill and completed both her OB/GYN residency and Complex Family Planning fellowship at OHSU. Dr. Liberty's clinical and research focus sits at the intersection of contraception and breast health — including the role of androgenic progestins in mammary tissue, progesterone receptor modulators in breast physiology and cancer prevention, and contraceptive access for patients facing cancer diagnoses. Her peer-reviewed work includes publications on progesterone receptor modulators in breast biology and cancer prevention, and she serves as Principal Investigator on active research at OHSU's Center for Women's Health.

  • Dr. Mary Jane Minkin, MD, FACOG, office headshot — Yale menopause faculty for OncoMenopause CME

    Mary Jane Minkin, MD, FACOG

    Clinical Professor, Obstetrics, Gynecology & Reproductive Sciences
    Yale University School of Medicine

    Dr. Mary Jane Minkin is a clinical professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the Yale University School of Medicine and has been in private practice in New Haven (CT) for more than 40 years. Dr. Minkin is board-certified in obstetrics and gynecology, and she practices at Yale-New Haven Hospital. She earned her medical degree from Yale Medical School and her undergraduate degree from Brown University. She did both her internship and residency at Yale-New Haven Hospital, the former in internal medicine, the latter in obstetrics and gynecology. She is a fellow of the American Congress of Obstetricians and Gynecologists (FACOG), and has been a North American Menopause Society Certified Menopause Practitioner (NCMP) since 2002. Dr. Minkin has been Director of the Sexuality, Intimacy and Menopause clinic in the Division of Gynecological Oncology, in the Smilow cancer center at Yale New Haven Hospital since 2008. She has also been Director of the Yale Obstetrical and Gynecological Society (YOGS) since its inception in 2006. 

  • Dr. James Simon, MD, headshot — George Washington University faculty for OncoMenopause CME

    James A. Simon, MDMD, CCD, MSCP, IF, FACOG

    Clinical Professor of Obstetrics and Gynecology, George Washington University
    Medical Director and Founder
    IntimMedicine Specialists

    Washington, DC

    Dr. James Simon is a board-certified OB/GYN and reproductive endocrinologist based in Washington, D.C. and a Clinical Professor of obstetrics and gynecology at George Washington University School of Medicine. Dr. Simon specializes in patient-focused care for women spanning the reproductive life cycle, from adolescence to childbirth through menopause.

    He has served as principal investigator on more than 400 clinical trials, research grants and scholarships related to women’s health, and the author of more than 800 published articles, abstracts, chapters, and the paperback book: Restore Yourself: A Woman’s Guide to Reviving Her Sexual Desire and Passion for Life.

    Dr. Simon earned his bachelor’s degree from Washington University in St. Louis and his medical degree from Rush Medical College in Chicago. He completed an internship and residency in obstetrics and gynecology at The George Washington University Hospital and a fellowship in endocrinology and infertility at Harbor-University of California, Los Angeles Medical Center.

  • Jennifer Lanoff, WHNP-BC, headshot — Washington DC menopause faculty for OncoMenopause CME

    Jennifer Lanoff, WHNP-BC, MSCP, JD

    Women’s Health and Gender-Related Nurse Practitioner
    Reiter, Hill, and Johnson

    Washington, DC

    Jennifer Lanoff, WHNP-BC, MSCP, JD, is a board-certified Women's Health and Gender-Related Nurse Practitioner with a GYN-only practice at Reiter, Hill and Johnson, an Advantia Practice, seeing patients in Washington, DC, Chevy Chase, MD, and Falls Church, VA. She specializes in menopause, osteoporosis, complex sexual health disorders, pelvic floor dysfunction, incontinence, hypoactive sexual desire disorder, persistent genital arousal disorder, and vulvovaginal disorders including vulvodynia, lichen sclerosus, and GSM, alongside well-woman care.

    A Menopause Society Certified Provider, Jennifer chairs the Menopause Society Education Committee and sits on its Trustee Nominating Committee. She also serves on Ms. Medicine's Physician Executive Group, The Body Agency's Medical Expert Board, and the National Menopause Foundation's Medical Advisory Committee, with memberships in leading women's health, sexual health, and bone health organizations.

    Jennifer studied at Stanford University, earned her MSN from Johns Hopkins, and her WHNP degree from Georgetown. Before medicine, she practiced law for over 20 years as a trial and appellate attorney at the DC Public Defender Service, holding a JD from the University of Michigan Law School.

  • Dr. Erin Duralde, MD, office headshot — One Medical menopause faculty for OncoMenopause CME

    Erin Duralde, MD, MPH, MSCP

    Medical Director of Menopause Care and Women’s Health - Clinical Effectiveness
    Primary Care and Menopause Physician
    Beverly Hills, California


    Dr. Erin Duralde is an internist, menopause specialist, and Medical Director of Women's Health - Clinical Effectiveness at One Medical, where she leads menopause care design and delivery. She has scaled integration of this essential care across over 20 metro areas. Before joining One Medical in 2023, she practiced at Brigham and Women's Hospital's Menopause and Midlife clinic in Boston. Erin earned her MD from the University of California, San Francisco, completed her internal medicine residency at Beth Israel Deaconess Medical Center, and holds a Master of Public Health from the Harvard School of Public Health. She has completed fellowships in both population health management and menopause management. Board-certified in internal medicine and a Menopause Society Certified Practitioner, Erin actively researches women's quality of life and barriers to care, recently co-authoring a state-of-the-art review on menopause management for the British Medical Journal. Her focus is on bridging the gap between research and practice, making menopause care more personalized, accessible and empowering for every person navigating this transition and beyond.

  • Dr. Amy Comander, MD, headshot — Mass General breast oncology faculty for OncoMenopause CME

    Amy Comander, MD, DipABLM

    Director, Breast Oncology Program
    Director, Lifestyle Medicine
    Mass General Cancer Center
    Waltham, Massachusetts

    Dr. Amy Comander is a board-certified breast oncologist and Director of the Breast Oncology Program at Mass General Cancer Center at Waltham and Newton-Wellesley Hospital. She also serves as Director of Lifestyle Medicine at Mass General Cancer Center, where she works to integrate lifestyle medicine into cancer care to improve long-term survivorship outcomes. Dr. Comander's clinical focus centers on helping breast cancer survivors navigate menopause and long-term health through evidence-based approaches that combine oncologic care with practical, sustainable lifestyle strategies.

WHAT YOU’LL LEAVE WITH


Four things you can use the next week in clinic

Practical frameworks

Real cases and hard questions — not a theoretical review.

Where evidence ends

What the data shows, what it doesn't, and where nuance is required.

The modern landscape

Hormonal and newer targeted nonhormonal options, and how they fit.

A team approach

Menopause, oncology, breast health, GYN, and sexual medicine together.

THE PROGRAM


What's on the Agenda?

Time
Session & Format
panel
7:00 – 7:45 AM
Non‑CMEBreakfast & Industry
7:45 – 8:00 AM
Non‑CMEWelcome & Slide Poll
Larkin & Lustberg
8:00 – 8:45 AM
LectureBreast Cancer Basics: What Every Women's Health Clinician Needs to Know
Larkin
8:45 – 9:30 AM
Case PanelContraception & Menopause in High-Risk Women and Survivors
Lustberg
9:30 – 11:00 AM
Case PanelMenopause Management After Breast Cancer
Larkin
11:00 AM – 12:00 PM
Case PanelHSDD & Sexual Health After Breast Cancer
Lustberg
12:00 – 12:30 PM
Q&AOpen Audience Discussion
Larkin & Lustberg

Early-bird registration - $275 (ends August 31, 2026) — $325 general registration after early-bird closes.

Final faculty to be confirmed.

LOGISTICS


What to know before you go?

Date
Tuesday
October 20, 2026
Time
7:00 AM – 12:30 PM
Breakfast included
Location
Omni San Diego
Hotel at the Ballpark
Registration
$275 Early-Bird
$325 general registration

FREQUENTLY ASKED QUESTIONS


What Clinicians Ask Before They Register

GET EARLY-BIRD ALERTS


Seats are limited to keep the case discussions clinically useful

Join Dr. Larkin and Dr. Lustberg for a morning built around real decisions — get notified the moment early-bird registration opens for the Omni San Diego program.

$275 early-bird · $325 general registration · 4.5 AMA PRA Category 1 Credits™ · Breakfast included

No separate trip. No extra day off. Make the most of San Diego.